377 related articles for article (PubMed ID: 24513805)
1. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.
Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA
Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of hepatocellular carcinoma in Hispanics in the United States.
El-Serag HB; Lau M; Eschbach K; Davila J; Goodwin J
Arch Intern Med; 2007 Oct; 167(18):1983-9. PubMed ID: 17923599
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.
Altekruse SF; McGlynn KA; Reichman ME
J Clin Oncol; 2009 Mar; 27(9):1485-91. PubMed ID: 19224838
[TBL] [Abstract][Full Text] [Related]
4. State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States.
Lee YT; Wang JJ; Luu M; Tseng HR; Rich NE; Lu SC; Nissen NN; Noureddin M; Singal AG; Yang JD
Hepatology; 2021 Sep; 74(3):1384-1394. PubMed ID: 33728665
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States.
Rich NE; Yopp AC; Singal AG; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):242-248.e5. PubMed ID: 31042582
[TBL] [Abstract][Full Text] [Related]
6. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention.
Yang B; Liu JB; So SK; Han SS; Wang SS; Hertz A; Shariff-Marco S; Lin Gomez S; Rosenberg PS; Nguyen MH; Hsing AW
Cancer; 2018 Sep; 124(17):3551-3559. PubMed ID: 30113700
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
White DL; Thrift AP; Kanwal F; Davila J; El-Serag HB
Gastroenterology; 2017 Mar; 152(4):812-820.e5. PubMed ID: 27889576
[TBL] [Abstract][Full Text] [Related]
8. Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA.
El-Serag HB; Sardell R; Thrift AP; Kanwal F; Miller P
Dig Dis Sci; 2021 Mar; 66(3):912-916. PubMed ID: 32303951
[TBL] [Abstract][Full Text] [Related]
9. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
10. Geographic variation within the United States in the incidence of hepatocellular carcinoma.
Davila JA; Petersena NJ; Nelson HA; El-Serag HB
J Clin Epidemiol; 2003 May; 56(5):487-93. PubMed ID: 12812824
[TBL] [Abstract][Full Text] [Related]
11. Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States.
Han SS; Kelly SP; Li Y; Yang B; Nguyen M; So S; Rosenberg PS; Hsing AW
J Natl Cancer Inst; 2019 Jun; 111(6):550-556. PubMed ID: 30544184
[TBL] [Abstract][Full Text] [Related]
12. Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018.
Alvarez CS; Petrick JL; Parisi D; McMahon BJ; Graubard BI; McGlynn KA
Hepatology; 2022 Sep; 76(3):589-598. PubMed ID: 35124828
[TBL] [Abstract][Full Text] [Related]
13. National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.
Ahmed F; Perz JF; Kwong S; Jamison PM; Friedman C; Bell BP
Prev Chronic Dis; 2008 Jul; 5(3):A74. PubMed ID: 18558024
[TBL] [Abstract][Full Text] [Related]
14. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.
Ryerson AB; Eheman CR; Altekruse SF; Ward JW; Jemal A; Sherman RL; Henley SJ; Holtzman D; Lake A; Noone AM; Anderson RN; Ma J; Ly KN; Cronin KA; Penberthy L; Kohler BA
Cancer; 2016 May; 122(9):1312-37. PubMed ID: 26959385
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic status and hepatocellular carcinoma in the United States.
Shebl FM; Capo-Ramos DE; Graubard BI; McGlynn KA; Altekruse SF
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1330-5. PubMed ID: 22669949
[TBL] [Abstract][Full Text] [Related]
16. Striking Racial/Ethnic Disparities in Liver Cancer Incidence Rates and Temporal Trends in California, 1988-2012.
Pham C; Fong TL; Zhang J; Liu L
J Natl Cancer Inst; 2018 Nov; 110(11):1259-1269. PubMed ID: 29617913
[TBL] [Abstract][Full Text] [Related]
17. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
18. Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030.
Petrick JL; Kelly SP; Altekruse SF; McGlynn KA; Rosenberg PS
J Clin Oncol; 2016 May; 34(15):1787-94. PubMed ID: 27044939
[TBL] [Abstract][Full Text] [Related]
19. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
Hausauer AK; Keegan TH; Chang ET; Clarke CA
Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
[TBL] [Abstract][Full Text] [Related]
20. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.
Clarke MA; Devesa SS; Harvey SV; Wentzensen N
J Clin Oncol; 2019 Aug; 37(22):1895-1908. PubMed ID: 31116674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]